ATPIF1-driven metabolic remodeling in osteoclasts promotes age-related cortical bone loss
Abstract
Age-related cortical bone loss is driven in part by increased osteoclast activity, but the mechanisms that sustain osteoclast function during skeletal aging remain poorly defined. Here, we show that aging remodels osteoclast metabolism, increasing glycolytic ATP production and reshaping metabolites linked to early tricarboxylic acid (TCA) cycle metabolism. Metabolomic profiling identified a glycolysis-coupled TCA node marked by increased isocitrate and α-ketoglutarate in aged osteoclasts. These cells also exhibited prolonged survival and reduced activation of regulated cell-death pathways; in mice, this was accompanied by increased bone resorption, while human osteoclasts from aged donors similarly showed prolonged persistence. Mechanistically, ATPase inhibitory factor 1 (ATPIF1) was required for this aging-associated metabolic state. Osteoclast-lineage deletion of Atpif1 reduced IDH3A expression, α-ketoglutarate accumulation, glycolytic ATP production, and resorptive function ex vivo, while attenuating age-related cortical bone loss and porosity in vivo. Pharmacologic perturbation of IDH3-linked metabolism similarly suppressed glycolytic ATP production and osteoclast activity and increased cortical bone mass in aged mice. Together, these findings identify glycolysis-centered metabolic rewiring as a mechanism that sustains osteoclast survival and resorption during skeletal aging and implicate an ATPIF1–IDH3A metabolic axis as a potential therapeutic target for age-associated osteoporosis.
Related
- Monocyte-Mimetic Nanoparticle Delivery of Verteporfin Promotes Plaque-Stabilizing Remodeling in Atherosclerosis
- ATP6AP2 in osteoblasts couples cortical bone matrix remodeling to osteocyte maturation via MMP14 activation in mice
- Metabolic Remodeling in Peritoneal Dialysis-Associated Peritoneal Fibrosis: Mechanisms, Candidate Metabolic Signatures, and Therapeutic Perspectives
- Mechanosignaling Promotes Macrophage Apoptosis Resistance in Pulmonary Fibrosis via Metabolic Reprogramming
- Honokiol, a structurally defined natural product, promotes SIRT3-linked bone formation in osteoporotic bone remodeling and fracture repair.
BibTeX
@misc{kim2026atpif1driven,
title = {{ATPIF1-driven metabolic remodeling in osteoclasts promotes age-related cortical bone loss}},
author = {Ha-Neui Kim and Gareeballah Adam and Ankita Chalke and Aaron Warren and Kimberly Richardson and Adriana Marques-Carvalho and Mikesha Carter and Hanwen Fan and Yuxiao Zhou and Jeff Thostenson and Farah Alturkmani and Benjamin Stronach and Jeffrey Stambough and Elena Ambrogini and Se-Ran Jun and Maria Almeida},
howpublished = {Research Square},
year = {2026},
month = oct,
doi = {10.21203/rs.3.rs-11273064/v1},
url = {https://doi.org/10.21203/rs.3.rs-11273064/v1},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - ATPIF1-driven metabolic remodeling in osteoclasts promotes age-related cortical bone loss
AU - Ha-Neui Kim
AU - Gareeballah Adam
AU - Ankita Chalke
AU - Aaron Warren
AU - Kimberly Richardson
AU - Adriana Marques-Carvalho
AU - Mikesha Carter
AU - Hanwen Fan
AU - Yuxiao Zhou
AU - Jeff Thostenson
AU - Farah Alturkmani
AU - Benjamin Stronach
AU - Jeffrey Stambough
AU - Elena Ambrogini
AU - Se-Ran Jun
AU - Maria Almeida
PY - 2026
DA - 2026/10/29
PB - Research Square
DO - 10.21203/rs.3.rs-11273064/v1
UR - https://doi.org/10.21203/rs.3.rs-11273064/v1
AB - Age-related cortical bone loss is driven in part by increased osteoclast activity, but the mechanisms that sustain osteoclast function during skeletal aging remain poorly defined. Here, we show that aging remodels osteoclast metabolism, increasing glycolytic ATP production and reshaping metabolites linked to early tricarboxylic acid (TCA) cycle metabolism. Metabolomic profiling identified a glycolysis-coupled TCA node marked by increased isocitrate and α-ketoglutarate in aged osteoclasts. These cells also exhibited prolonged survival and reduced activation of regulated cell-death pathways; in mice, this was accompanied by increased bone resorption, while human osteoclasts from aged donors similarly showed prolonged persistence. Mechanistically, ATPase inhibitory factor 1 (ATPIF1) was required for this aging-associated metabolic state. Osteoclast-lineage deletion of Atpif1 reduced IDH3A expression, α-ketoglutarate accumulation, glycolytic ATP production, and resorptive function ex vivo, while attenuating age-related cortical bone loss and porosity in vivo. Pharmacologic perturbation of IDH3-linked metabolism similarly suppressed glycolytic ATP production and osteoclast activity and increased cortical bone mass in aged mice. Together, these findings identify glycolysis-centered metabolic rewiring as a mechanism that sustains osteoclast survival and resorption during skeletal aging and implicate an ATPIF1–IDH3A metabolic axis as a potential therapeutic target for age-associated osteoporosis.
SN - 2693-5015
ER -